Diagnostic and Prognostic Models

105 Items

All Items

Multiomics analysis of homologous recombination deficiency across cancer types

Lin Dong, Lin Li, Linyan Zhu, Fei Xu, Rumeng Zhang, Qiushuang Li, Yong Zhu, Zhutian Zeng, Keshuo Ding

71–81
Molecular classification of muscle-invasive bladder cancer based on a simplified immunohistochemical panel using GATA3, CK5/6 and p16

Robert Terlević, Monika Ulamec, Goran Štimac, Jure Murgić, Božo Krušlin

968–975
Molecular classification and fertility-sparing outcomes in endometrial cancer and atypical endometrial hyperplasia

Jiayi Wang, Guozhong Jiang, Shuping Yan, Yanpeng Tian, Yuxi Jin, Hanlin Fu, Lulu Si, Mingbo Cai, Xueyan Liu, Ruixia Guo

471–482
Molecular biomarkers involved in the progression of gallbladder inflammatory lesions to invasive cancer: A proteomic approach

Neetu Rawal, Gururao Hariprasad, Sabyasachi Bandyopadhyay, Nihar Ranjan Dash, Sunil Kumar, Prasenjit Das, Sharmistha Dey, Maroof Ahmad Khan, Amar Ranjan, Anita Chopra, Sundeep Saluja, Showket Hussain, G.K. Rath, Tanvir Kaur , Pranay Tanwar

115–143
MicroRNAs expression profile in chemotherapy-induced cardiotoxicity in non-small cell lung cancer using a co-culture model

Mihai Romitan, Oana Zanoaga, Liviuta Budisan, Ancuta Jurj, Lajos Raduly, Laura Pop, Cristina Ciocan, Radu Pirlog, Cornelia Braicu, Tudor Eliade Ciuleanu, Ioana Berindan-Neagoe

125–137
Methylation pattern of caveolin-1 in prostate cancer as potential cfDNA biomarker

Lucija Škara, Tonći Vodopić, Ivan Pezelj, Irena Abramovic, Borna Vrhovec, Alen Vrtarić, Nino Sincic, Davor Tomas, Stela Bulimbašić, Tomislav Kuliš, Monika Ulamec

176-186
Machine learning to improve prognosis prediction of metastatic clear-cell renal cell carcinoma treated with cytoreductive nephrectomy and systemic therapy

Wenjie Yang, Lin Ma, Jie Dong, Mengchao Wei, Ruoyu Ji, Hualin Chen, Xiaoqiang Xue, Yingjie Li, Zhaoheng Jin, Weifeng Xu, Zhigang Ji

471–482
Machine learning integration of single-cell and bulk transcriptomics identifies fibroblast-driven prognostic markers in colorectal cancer

Ning Zhang, Ruiyan Liu, Siya Wu, Chenxi Feng, Boxiang Wang, Qiaoqiao Zheng, Linru Jie, Ruihua Kang, Xiaoli Guo, Xiaoyang Wang, Shaokai Zhang, Jiangong Zhang

115–131
Machine learning for predicting the survival in osteosarcoma patients: Analysis based on American and Hebei Province cohort

Yahui Hao, Di Liang, Shuo Zhang, Siqi Wu, Daojuan Li, Yingying Wang, Miaomiao Shi, Yutong He

883–893
Lymph node ratio is a prognostic indicator for locally advanced esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy

Pengcheng Chen, Liang Wang, Xun Yang, Jifeng Feng

159–169
Low expression of CADPS predicts poor prognosis in pediatric acute lymphoblastic leukemia without fusion genes

Bin Zhang, Chaoran Shi, Xiuxiu Wang, Jiajia Mi, Runan Wang, Shuang Li, Jiawei Yang, Qiuying He, Yujiao Wang, Zuofei Chi, Liangchun Hao

2295–2307
JAM3: A prognostic biomarker for bladder cancer via epithelial–mesenchymal transition regulation

Zhong-qi Pang, Jian-she Wang, Jin-feng Wang, Ya-xuan Wang, Bo Ji, Yi-dan Xu, Jia-xin He, Lu Zhang, Li-qiu Zhang, Bei-chen Ding, Yang Liu, Ming-hua Ren

897-911
Integrating bioinformatics and experimental models to investigate the mechanism of the chelidonine-induced mitotic catastrophe via the AKT/FOXO3/FOXM1 axis in breast cancer cells

Huimin Li, Xiyu Tang, Zhiwei Sun, Zhongyuan Qu, Xiang Zou

560–574
Increased co-expression of TIM-3 with TIGIT or 2B4 on CD8+ T cells is associated with poor prognosis in locally advanced nasopharyngeal carcinoma

Xiaolin Xie, Yaning Feng, Peiwen Fan, Danning Dong, Xuan Yao, Yanchun Peng, Ruozheng Wang

584–595
Incorporating ultrasound-based lymph node staging significantly improves the performance of a clinical nomogram for predicting preoperative axillary lymph node metastasis in breast cancer

Xiaomin Wang, Xiaoping Yi, Qian Zhang, Xiaoxiao Wang, Hanghao Zhang, Shuai Peng, Kuansong Wang, Liqiu Liao

680–688
Impact of TLR9 and TLR7 gene polymorphisms on prognosis and survival of patients with oral squamous cell carcinoma

Miroslav Obrenović, Gordana Šupić, Satoru Miyabe, Irena Mladenović, Ružica Kozomara, Saša Jović, Aleksandra Petković Ćurčin, Debora Štefik, Srboljub Stosić, Biserka Vukomanović Đurđević

1682–1691
Immunogenic cell death-related risk signature for tumor microenvironment profiling and prognostic prediction in colorectal cancer

Pengcheng Wang, Wei Zhao, Linghong Guo, Hailei Cao

2281–2294
Identification of RUNX1 and IFNGR2 as prognostic-related biomarkers correlated with immune infiltration and subtype differentiation of low-grade glioma

Xia Zhang, Hongyu Chu, Yuan Cheng, Jie Ren, Wei Wang, Xicheng Liu, Xiaodong Yan

405–425
Global Immune-Nutrition-Inflammation Index as a novel comprehensive biomarker in predicting the radiation-induced trismus rates in locally advanced nasopharyngeal carcinoma patients

Efsun Somay, Erkan Topkan, Sibel Bascil, Nilüfer Kılıc Durankuş, Şükran Senyürek, Düriye Ozturk, Berrin Pehlivan, Ugur Selek

1703–1710
Gastrointestinal diffuse large B-cell lymphoma: Clinical characteristics and prognostic analysis from SEER database

Fang Du, Lingyun Zhou, Runya Fang, Jiao Chen, Danbo Liu, Hongxian Xiang, Wenyi Lu, Jingsong Wu, Haifei Chen

2666–2679

Previous 41-60 of 105 Next

Diagnostic and Prognostic Models

All Items

Multiomics analysis of homologous recombination deficiency across cancer types

Molecular classification of muscle-invasive bladder cancer based on a simplified immunohistochemical panel using GATA3, CK5/6 and p16

Molecular classification and fertility-sparing outcomes in endometrial cancer and atypical endometrial hyperplasia

Molecular biomarkers involved in the progression of gallbladder inflammatory lesions to invasive cancer: A proteomic approach

MicroRNAs expression profile in chemotherapy-induced cardiotoxicity in non-small cell lung cancer using a co-culture model

Methylation pattern of caveolin-1 in prostate cancer as potential cfDNA biomarker

Machine learning to improve prognosis prediction of metastatic clear-cell renal cell carcinoma treated with cytoreductive nephrectomy and systemic therapy

Machine learning integration of single-cell and bulk transcriptomics identifies fibroblast-driven prognostic markers in colorectal cancer

Machine learning for predicting the survival in osteosarcoma patients: Analysis based on American and Hebei Province cohort

Lymph node ratio is a prognostic indicator for locally advanced esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy

Low expression of CADPS predicts poor prognosis in pediatric acute lymphoblastic leukemia without fusion genes

JAM3: A prognostic biomarker for bladder cancer via epithelial–mesenchymal transition regulation

Integrating bioinformatics and experimental models to investigate the mechanism of the chelidonine-induced mitotic catastrophe via the AKT/FOXO3/FOXM1 axis in breast cancer cells

Increased co-expression of TIM-3 with TIGIT or 2B4 on CD8+ T cells is associated with poor prognosis in locally advanced nasopharyngeal carcinoma

Incorporating ultrasound-based lymph node staging significantly improves the performance of a clinical nomogram for predicting preoperative axillary lymph node metastasis in breast cancer

Impact of TLR9 and TLR7 gene polymorphisms on prognosis and survival of patients with oral squamous cell carcinoma

Immunogenic cell death-related risk signature for tumor microenvironment profiling and prognostic prediction in colorectal cancer

Identification of RUNX1 and IFNGR2 as prognostic-related biomarkers correlated with immune infiltration and subtype differentiation of low-grade glioma

Global Immune-Nutrition-Inflammation Index as a novel comprehensive biomarker in predicting the radiation-induced trismus rates in locally advanced nasopharyngeal carcinoma patients

Gastrointestinal diffuse large B-cell lymphoma: Clinical characteristics and prognostic analysis from SEER database

impact_factor_6

Sidebar_menu